Verastem, Inc. (VSTM)
7.65
+0.77
(+11.19%)
USD |
NASDAQ |
Jan 07, 16:00
7.55
-0.10
(-1.31%)
After-Hours: 18:01
Verastem Research and Development Expense (Annual): 81.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| Anavex Life Sciences Corp. | 37.59M |
| ADMA Biologics, Inc. | 1.813M |
| Ocugen, Inc. | 30.16M |
| Zevra Therapeutics, Inc. | 35.71M |